Nixon Gwilt Law

MARCH 6, 2025

On February 21, 2025 , the FDA officially determined that the shortage of semaglutide injection products has been resolved. When the FDA determines the drug shortage is resolved, the normal restrictions on compounding will apply once again. Those impacted must navigate critical regulatory changes now in play for compounded semaglutide.

FDA 52

FDA Physicians Distribution Medical 52

World of DTC Marketing

MARCH 11, 2022

Trust, for example, in physicians is still relatively high. Most patients completely trusted their physicians “to put their needs above all other considerations” (69%). Physician trust in the U.S. Physician trust in the U.S. Even patients will still line up if a prescription drug shows promise.

Physicians 212

Physicians Healthcare Healthcare Pharma 212

World of DTC Marketing

AUGUST 25, 2022

Still, consistent research has shown that they don’t provide the information patients want in a language that talks to them. Pharma companies have access to some of the best physicians in the country, and they are underutilized when helping patients understand health issues. So what’s the ROI?

Doctors 227

Doctors Media Physicians Pharma 227

World of DTC Marketing

AUGUST 10, 2022

Time and time again, I’ve found, in research talking with patients, that they want a lot more information before they ask for a new drug. They’re using label and FDA-friendly language, which isn’t what patients want to hear. Instead, patients are going online and spreading inaccurate information.

Marketing 252

Marketing Media Side effects Pharma 252

World of DTC Marketing

DECEMBER 29, 2021

The demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. There are also several physicians chiming in with their concerns over the long-term use of the drug. Wegovy can indeed help patients lose weight, but it requires that users adhere to a diet and exercise.

Side effects 191

Side effects Physicians Patients FDA 191

Legacy MEDSearch

SEPTEMBER 12, 2022

a company that provides Ear, Nose and Throat (ENT) physicians with non-invasive solutions to treat chronic nasal conditions, announced U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of a next-generation RhinAer® stylus. of patients positively responded to treatment at 24 months, defined as a ?30%

Medical 98

Medical Patients FDA Physicians 98

World of DTC Marketing

JUNE 2, 2021

Here are some basics: 1ne: Physicians receive a lot of emails and don’t have time to read every one. One of our tests, one of the most read emails, had a subject line of “new label information for prescribing just FDA approved.” Only send an email when you have something to say that will interest physicians.

Physicians 180

Physicians Doctors Marketing Sales 180

World of DTC Marketing

DECEMBER 23, 2020

DTC marketers who believe that DTC is essentially the same as before the pandemic are failing to recognize significant shifts in patient behavior regarding prescription drugs. In an era of a pandemic, are psoriasis patients really going to ask for a drug that may compromise their immune system? What are other patients saying about it?

Prescription 249

Prescription Doctors Side effects Marketing 249

World of DTC Marketing

NOVEMBER 5, 2021

Patients want quick fixes, and the idea of losing some weight because of a new drug is enticing to them. In response, the company has been providing six-month waivers to some insured patients that will cap the drug’s out-of-pocket costs at $25 a month, though the long-term picture of coverage is still in flux. Click to Tweet.

Insurance 271

Insurance Side effects Medical Prescription 271

European Pharmaceutical Review

SEPTEMBER 28, 2023

The US Food and Drug Administration (FDA) has approved Takeda’s single-dose pre-filled pen for ENTYVIO ® (vedolizumab) as a treatment for the chronic inflammatory disease ulcerative colitis. FDA’s approval is based on the Phase III VISIBLE 1 study (SC UC Trial).

Food and Drug Administration 104

Food and Drug Administration FDA Physicians Food 104

Pharma Marketing Network

APRIL 4, 2025

Thats why referral marketing is gaining traction among pharmaceutical brands looking to increase engagement with both healthcare professionals and patients. Similarly, when patients share their experiences with others, it can drive interest more effectively than brand messaging alone. In pharma, however, the dynamic is more nuanced.

Marketing 52

Marketing Pharma Education Physicians 52

MedCity News

JULY 27, 2023

Current applications Today, there is an escalated appetite to address emerging procedures because they offer an opportunity for device makers – and physicians like me who are interested in cutting-edge technology – to influence new areas of medicine. It is akin to pioneering the untamed West in the 18th Century.

Specialization 232

Specialization Medical Medicine Leads 232

Pharmaceutical Technology

FEBRUARY 5, 2023

The US Food and Drug Administration (FDA) has granted approval for Gilead Sciences ’ Trodelvy (sacituzumab govitecan-hziy) to treat unresectable locally advanced or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative (IHC 0, IHC 1+ or IHC 2+/ISH–) breast cancer adult patients.

Food and Drug Administration 105

Food and Drug Administration FDA Physicians Food 105

World of DTC Marketing

SEPTEMBER 24, 2021

Physicians and insurers are rejecting Aduhelm because it should never have been approved in the first place. This drug was never about patients; it was about a company whose ego got too big and needed a savior in the form of a medicine that could bring in hundreds of millions of dollars. Biogen is in trouble.

Insurance 222

Insurance Pharma Doctors Physicians 222

World of DTC Marketing

JANUARY 1, 2022

More and more patients demand a level of service they want with the increased costs of health insurance premiums. 1ne: The value proposition of prescription drugs still outweighs potential side effects – Wegovy’s demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections.

Healthcare 244

Healthcare Healthcare Side effects Prescription 244

World of DTC Marketing

DECEMBER 22, 2020

” An app can help patients manage their chronic conditions but there are a lot of variables. If, for existence, a pharma developed app requires patients to “check-in” everyday it could be a reminder that they are living with a chronic health issue. ” to “if it helps patient, it’s what we want to do.”

Pharma 230

Pharma Doctors Patients Management 230

pharmaphorum

JUNE 27, 2022

Jennifer Mathieu, director of government relations at the Academy of Managed Care Pharmacy (AMCP), tells us why the organisation backed the pre-approval information exchange (PIE) Act of 2022 and how the legislation will empower companies to share information with healthcare payers and plans during the FDA approval process. .

Food and Drug Administration 95

Food and Drug Administration Medical Patients FDA 95

European Pharmaceutical Review

OCTOBER 25, 2022

AstraZeneca’s Imfinzi (durvalumab) and Imjudo (tremelimumab) combination therapy has been approved in the US for adult patients with unresectable hepatocellular carcinoma (HCC). Phase III trial results found that three years post-treatment, 31 percent of patients given the drug combination were still alive.

Food and Drug Administration 111

Food and Drug Administration Patients Safety Physicians 111

Pharmaceutical Technology

FEBRUARY 20, 2023

The US Food and Drug Administration (FDA) has granted approval for Apellis Pharmaceuticals’ Syfovre (pegcetacoplan injection) to treat geographic atrophy (GA), an advanced form of age-related macular degeneration (AMD). The post US FDA approves Apellis’ geographic atrophy therapy Syfovre appeared first on Pharmaceutical Technology.

Food and Drug Administration 98

Food and Drug Administration FDA Physicians Food 98

Pharmaceutical Technology

MAY 29, 2023

Lexicon Pharmaceuticals (Lexicon) has received approval from the US Food and Drug Administration (FDA) for its Inpefa drug to treat heart failure. The SOLOIST-WHF (worsening heart failure) and SCORED trials together assessed around 12,000 patients.

Food and Drug Administration 98

Food and Drug Administration FDA Transportation Physicians 98

World of DTC Marketing

SEPTEMBER 22, 2021

Second, do people trust the FDA? ” 2wo: Physicians are still the gatekeepers of new Rx’s. For them, it’s about two things: relevant data that can be corroborated and improvements in patient outcomes. What does the data mean to the average patient, and why should they consider your product? 5ive: Please!

Doctors 43

Doctors Media Marketing Prescription 43

Pharmaceutical Technology

OCTOBER 1, 2022

The US Food and Drug Administration (FDA) has granted approval for Amylyx Pharmaceuticals’ Relyvrio (sodium phenylbutyrate and taurursodiol) to treat adult patients with amyotrophic lateral sclerosis (ALS). The FDA approval is based on findings from the multicentre Phase II CENTAUR clinical trial that enrolled 137 ALS patients.

Food and Drug Administration 97

Food and Drug Administration FDA Prescription Medicine 97

Legacy MEDSearch

APRIL 6, 2023

announced that it has received FDA 510(k) clearance for CardioSTAT, an ambulatory, continuous ECG monitoring solution that relies on a wire free, single-use recorder. The FDA clearance opens the door to the world’s largest medical device market. To this day, CardioSTAT has been prescribed to more than 170,000 patients.

Food and Drug Administration 98

Food and Drug Administration Food FDA Recruitment 98

pharmaphorum

SEPTEMBER 30, 2022

Patient organisations have been celebrating the FDA approval yesterday of Amylyx’ amyotrophic lateral sclerosis (ALS) therapy Relyvrio, after not one but two advisory committee meetings that arrived at different conclusions about the drug. An oral version of edaravone was cleared this year.

FDA 98

FDA Doctors Patients Prescription 98

Pharma Marketing Network

DECEMBER 5, 2024

These networksspanning healthcare professionals, patients, and digital platformsare the lifeblood of modern pharma marketing. In the pharmaceutical industry, these networks often include healthcare providers, patient groups, digital channels, and key opinion leaders (KOLs). Educate patients about treatments like Humira or Keytruda.

Networking 52

Networking Marketing Pharmaceutical Pharma 52

Pharma Marketing Network

MARCH 12, 2025

In a highly regulated industry, choosing the right keywords can determine whether your ads reach healthcare professionals, patients, or caregivers effectively. Understanding how patients and healthcare professionals search for medical information is key. Using FDA-approved terminology prevents ad disapprovals and regulatory scrutiny.

Marketing 59

Marketing Pharma Prescription Competition 59

Legacy MEDSearch

SEPTEMBER 16, 2022

Food and Drug Administration (FDA) has cleared its Tasso+ lancet as a Class II medical device. Healthcare systems and physicians will also be able to use the Tasso+ device with compatible collection tubes to make determinations on blood chemistries for their patients and expand care access. Tasso, Inc., About Tasso.

Medical 97

Medical FDA Food and Drug Administration Recruitment 97

MedCity News

JULY 23, 2024

The promise of these and other food allergy treatments is immense and research and development, in conjunction with clinical care facilities for food allergy patients, will continue to make more treatment options available for more people in the future.

Food 283

Food Patients FDA Physicians 283

Legacy MEDSearch

NOVEMBER 9, 2022

announced that over 1,200 patients have been treated with the Early Bird® Bleed Monitoring System, the first and only FDA-approved bleed detection system. The adoption of the Early Bird system is a testimony to physicians embracing the benefits of early bleed detection for their patients and practice.”. “We Saranas, Inc.

Patients 98

Patients Food and Drug Administration Physicians Recruitment 98

Pharmaceutical Technology

AUGUST 12, 2022

In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research. The FDA’s action plan. Thus, FDA funding could be what is needed on this front, says Cudkowicz.

FDA 98

FDA Food and Drug Administration Physicians Side effects 98

World of DTC Marketing

JULY 5, 2022

Pharma websites provide the prescription that can help people overcome health problems but too often, they ignore the patient’s responsibility to lose weight and exercise. The FDA should require every pharma product website to devote part of its content to prevention and the importance of exercise.

Insurance 200

Insurance Doctors Pharma Side effects 200

Legacy MEDSearch

OCTOBER 25, 2022

Food and Drug Administration (FDA) granted Breakthrough Device Designation for the Company’s EndoStim System. “We are pleased that the FDA has recognized the therapeutic potential of the EndoStim System as a new treatment in development for drug refractory GERD,” said Eric Goorno, Chief Executive Officer of EndoStim. .

Food and Drug Administration 98

Food and Drug Administration FDA Recruitment Side effects 98

Pharmaceutical Technology

AUGUST 12, 2022

In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses. million people in the UK and 2.7

Food and Drug Administration 141

Food and Drug Administration Pharmacology Side effects Physicians 141

Pharmaceutical Technology

APRIL 4, 2023

Vertex Pharmaceuticals and CRISPR Therapeutics have completed the rolling submission of biologics licence applications (BLAs) to the US Food and Drug Administration (FDA) for exagamglogene autotemcel (exa-cel) to treat sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT).

Food and Drug Administration 98

Food and Drug Administration FDA Medicine Pharmaceutical 98

pharmaphorum

JULY 7, 2022

Pfizer is still waiting for the green light to complete an acquisition of digital health company ResApp, a deal that looks even better now that its smartphone app for people with obstructive sleep apnoea (OSA) has been approved by the FDA. The post ResApp bags FDA okay for sleep apnoea app, after Pfizer takeover bid appeared first on.

FDA 105

FDA Prescription Healthcare Provider Patients 105

Legacy MEDSearch

DECEMBER 19, 2022

Chairman, Dave Ferrera, announced treatment of the first patients in North America with the BossStent® device designed to treat patients with symptomatic cerebral venous diseases. Both the EU and FDA clinical trials will be initiated in Q2 2023 for the purpose of obtaining European and US regulatory approvals respectively in Q1 2024.

Patients 98

Patients Recruitment Physicians Management 98

Pharma Marketing Network

JULY 26, 2023

The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled.

Marketing 97

Marketing FDA Food and Drug Administration Pharmaceutical 97